Skip to main content
. 2017 Aug 16;11:2359–2372. doi: 10.2147/DDDT.S138922

Table 3.

DEX in vasoproliferative retinal tumors

Reference Study design No of eyes Previous treatment Treatment Follow-up Retreatment BCVA CMT Complications
Cebeci et al48 Case report 3 IVT BEV
Laser photocoagulation
DEX 12 months 1 DEX + PDT
(1 week after)
From 20/25 to 20/40 NR 1 subcapsular cataract

Abbreviations: BCVA, best corrected visual acuity; BEV, bevacizumab; CMT, central macular thickness; DEX, dexamethasone implant; IVT, intravitreal; NR, not reported; PDT, photodynamic therapy.